Ignite Creation Date:
2024-05-06 @ 12:59 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03907605
Status:
COMPLETED
Last Update Posted:
2019-04-09
First Post:
2019-04-06
Brief Title:
Anti-Mullerian Hormone AMH is a Marker for Ovarian Reserve There Are Many Studies About AMH Changes in Ovarian Surgery But Little is Known for Other Surgeries We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage PPH
Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Organization:
Kanuni Sultan Suleyman Training and Research Hospital
Study Overview
Official Title:
Comparison of Serum Anti-Mullerian Hormone Levels Following Uterine Artery Ligation for PPH
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Anti-Mullerian hormone AMH is a marker for ovarian reserve There are many studies about AMH changes in ovarian surgery but little is known for other surgeries We seek to investigate the hormone variations before and after uterine artey ligation for postpartum hemorrage PPH
Detailed Description:
All patients belong to the same group The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None